Reed Jobs was a man of love who laughed and loved his work. Although he was the son of Steve Jobs, the late Apple founder, he preferred to talk about his work in the field of biotechnologies, especially the biotech venture company Yosemite, which he founded in 2023. Jobs hopes to promote innovation in cancer treatment by combining charitable and traditional risk investments.
In a dialogue with TechCrunch, Jobs indicated that Yosemite was now active, that the team had been expanded to 17 and that he had confidence in AI ' s application in drug detection and clinical trial design. He mentioned that Yosemite ' s investment strategy was concentrated in the field of oncology, with the goal of developing new drugs through itself rather than relying solely on existing research by pharmaceutical companies.
Jobs also mentioned that the biotech industry is recovering from the epidemic and that pharmaceutical companies are facing the largest number of patent expirations in history, which offers great opportunities for emerging companies. In his view, AI was changing the way health care delivery was delivered, particularly in clinical trials, and its application could significantly reduce costs and increase efficiency.
Turning to the future, Jobs stated that the goal of Yosemite was to create new areas of medicine and promote progress in cancer treatment, and hoped to continue to lead industry in future investments.